Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$120,000.00
Identification and Validation of Fibromyalgia Phenotypes: Reducing Heterogeneity to Create Personalized Treatments
EF 2024-25
Résumé
Fibromyalgia (FM) is a complex, chronic pain condition affecting millions of Canadians. Symptoms vary greatly from person to person: some individuals live with constant, widespread muscle pain, while others experience intense fatigue, sleep disturbances, or mental health challenges like anxiety and depression. This wide range of symptoms makes it challenging for healthcare providers to find effective treatments, often resulting in frustration for both patients and providers. Research suggests that FM patients may belong to distinct subgroups, or "phenotypes," based on differences in biological, psychological, or social factors. Identifying these subgroups could allow for more targeted, effective treatments tailored to each person's needs.
My research aims to define these FM subgroups by analyzing data from existing studies and two large FM patient populations. First, I will review current research to identify potential risk factors and causes that may suggest different FM subtypes. Next, I will collaborate with healthcare providers and FM patients to explore how these subtypes could be applied in real-world clinical settings. Finally, I will test these subtypes against data from large FM populations to ensure they are relevant and broadly applicable.
Once identified, these FM subtypes will be available to healthcare providers and researchers to improve patient care. By tailoring treatments to individual needs, this research could increase the likelihood of symptom relief and enhance quality of life for FM patients. On a larger scale, understanding these subtypes could help reduce the public health impact of FM by equipping healthcare providers with better tools to manage the condition. Additionally, this work could streamline patient care by introducing a triage system that guides providers in matching patients with the most effective treatments based on their subtype, making healthcare delivery more efficient and improving outcomes for FM patients across Canada.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
518328
Name
Steen Jeremy P
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Doctoral Research Awards - B
Projecttitle
Identification and Validation of Fibromyalgia Phenotypes: Reducing Heterogeneity to Create Personalized Treatments
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Biostatistics; Chronic Pain; Clinical Research; Fibromyalgia; Healthcare Delivery; Musculoskeletal Pain; Pain Management; Personalized Medicine
Abstract
Fibromyalgia (FM) is a complex, chronic pain condition affecting millions of Canadians. Symptoms vary greatly from person to person: some individuals live with constant, widespread muscle pain, while others experience intense fatigue, sleep disturbances, or mental health challenges like anxiety and depression. This wide range of symptoms makes it challenging for healthcare providers to find effective treatments, often resulting in frustration for both patients and providers. Research suggests that FM patients may belong to distinct subgroups, or "phenotypes," based on differences in biological, psychological, or social factors. Identifying these subgroups could allow for more targeted, effective treatments tailored to each person's needs.
My research aims to define these FM subgroups by analyzing data from existing studies and two large FM patient populations. First, I will review current research to identify potential risk factors and causes that may suggest different FM subtypes. Next, I will collaborate with healthcare providers and FM patients to explore how these subtypes could be applied in real-world clinical settings. Finally, I will test these subtypes against data from large FM populations to ensure they are relevant and broadly applicable.
Once identified, these FM subtypes will be available to healthcare providers and researchers to improve patient care. By tailoring treatments to individual needs, this research could increase the likelihood of symptom relief and enhance quality of life for FM patients. On a larger scale, understanding these subtypes could help reduce the public health impact of FM by equipping healthcare providers with better tools to manage the condition. Additionally, this work could streamline patient care by introducing a triage system that guides providers in matching patients with the most effective treatments based on their subtype, making healthcare delivery more efficient and improving outcomes for FM patients across Canada.
Competitiondate
202411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Steen, Jeremy P
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~